These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 17425704)

  • 41. Migraine in the triptan era: lessons from epidemiology, pathophysiology, and clinical science.
    Bigal ME; Ferrari M; Silberstein SD; Lipton RB; Goadsby PJ
    Headache; 2009 Feb; 49 Suppl 1():S21-33. PubMed ID: 19161562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluating the efficacy of migraine therapy.
    Chawluk JB
    Postgrad Med; 2000 Sep; 108(3 Suppl):16-21. PubMed ID: 19667526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Future pharmacologic targets for acute and preventive treatments of migraine.
    Buchanan TM; Ramadan NM; Aurora S
    Expert Rev Neurother; 2004 May; 4(3):391-430. PubMed ID: 15853537
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Almotriptan: meeting today's needs in acute migraine treatment.
    Láinez MJ
    Expert Rev Neurother; 2007 Dec; 7(12):1659-73. PubMed ID: 18052762
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of perimenstrual migraine with triptans: an update.
    Casolla B; Lionetto L; Candela S; D'Alonzo L; Negro A; Simmaco M; Martelletti P
    Curr Pain Headache Rep; 2012 Oct; 16(5):445-51. PubMed ID: 22644903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Triptans vs other drugs for acute migraine.
    Steiner T
    Headache; 2008 Oct; 48(9):1378-9. PubMed ID: 18793208
    [No Abstract]   [Full Text] [Related]  

  • 47. Sumatriptan: a decade of use and experience in the treatment of migraine.
    Sheftell FD; Bigal ME; Tepper SJ; Rapoport AM
    Expert Rev Neurother; 2004 Mar; 4(2):199-209. PubMed ID: 15853561
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy.
    De Vries P; Villalón CM; Saxena PR
    Eur J Pharmacol; 1999 Jun; 375(1-3):61-74. PubMed ID: 10443565
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
    Chen LC; Ashcroft DM
    Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Side effects of triptans].
    Igarashi H
    No To Shinkei; 2004 Sep; 56(9):754-9. PubMed ID: 15552864
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
    Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Eletriptan: a review and new perspectives.
    Sandrini G; Perrotta A; Nappi G
    Expert Rev Neurother; 2006 Oct; 6(10):1413-21. PubMed ID: 17078782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Economic analysis of triptan therapy for acute migraine: a Medicaid perspective.
    Mullins CD; Subedi PR; Healey PJ; Sanchez RJ
    Pharmacotherapy; 2007 Aug; 27(8):1092-101. PubMed ID: 17655509
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination.
    Cady RK; Banks J; Jones BA; Campbell J
    Curr Med Res Opin; 2009 Nov; 25(11):2711-21. PubMed ID: 19778164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sumatriptan fast-disintegrating/rapid-release tablets in the acute treatment of migraine.
    Barbanti P; Le Pera D; Cruccu G
    Expert Rev Neurother; 2007 Aug; 7(8):927-34. PubMed ID: 17678486
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 5-hydroxytryptamine1B receptor and triptan response in migraine, lack of association with common polymorphisms.
    Velati D; Viana M; Cresta S; Mantegazza P; Testa L; Bettucci D; Rinaldi M; Sances G; Tassorelli C; Nappi G; Canonico PL; Martignoni E; Genazzani AA
    Eur J Pharmacol; 2008 Feb; 580(1-2):43-7. PubMed ID: 18035351
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adverse effects of medications commonly used in the treatment of migraine.
    Whyte CA; Tepper SJ
    Expert Rev Neurother; 2009 Sep; 9(9):1379-91. PubMed ID: 19769452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Triptans versus other migraine medicine--secondary publication].
    Tfelt-Hansen P
    Ugeskr Laeger; 2009 Apr; 171(18):1485-7. PubMed ID: 19425262
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Managing migraine: sustained treatment, minimal time. Introduction.
    Postgrad Med; 2000 Sep; 108(3 Suppl):3. PubMed ID: 19667523
    [No Abstract]   [Full Text] [Related]  

  • 60. More to be said on "Triptans vs other drugs for acute migraine. Are there differences in efficacy?".
    Hofmann R
    Headache; 2009 Feb; 49(2):312-3. PubMed ID: 18783444
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.